C-reactive protein, procalcitonin and interleukin-8 in the primary diagnosis of infections in cancer patients

被引:45
作者
Kallio, R
Surcel, HM
Bloigu, A
Syrjälä, H
机构
[1] Oulu Univ Hosp, Dept Infect Control, FIN-90220 Oulu, Finland
[2] Natl Publ Hlth Inst, Oulu, Finland
[3] Oulu Univ Hosp, Dept Oncol & Radiol, FIN-90220 Oulu, Finland
关键词
cancer; infection; C-reactive protein; procalcitonin; interleukin-8;
D O I
10.1016/S0959-8049(00)00018-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The diagnostic utility of C-reactive protein (CRP), procalcitonin (PCT) and interleukin-8 (IL-8) were studied in 66 cancer patients with suspected infection (39 with definite foci of infection, 17 with antibiotic responses without foci and 10 with neoplastic fever without infection) and 26 patients scheduled for chemotherapy. The infection group (n = 56) had higher median CRP (91 versus 19 mg/l, P < 0.001), PCT (0.28 versus 0.12 ng/ml, P < 0.001) and IL-8 values (27.7 versus 16.9 pg/ml, P = 0.032) than the noninfection group (n = 36). In patients with suspected infection, only PCT was a good marker to discriminate bacteraemia with an area under the receiver operating characteristics curve of 0.92 (95% confidence interval (CI), 0.77-1.0), but even PCT was less well able to differentiate between non-bacteraemic infections and neoplastic fever (0.56; 95% CI, 0.35-0.77). In conclusion, PCT was a good indicator for bacteraemia, but none of the three markers were reliable indicators for minor infections in non-neutropenic cancer patients. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:889 / 894
页数:6
相关论文
共 30 条
[1]  
[Anonymous], CLIN LAB
[2]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[3]   NEUTROPHIL-ACTIVATING PEPTIDE-1 INTERLEUKIN-8, A NOVEL CYTOKINE THAT ACTIVATES NEUTROPHILS [J].
BAGGIOLINI, M ;
WALZ, A ;
KUNKEL, SL .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04) :1045-1049
[4]   THE ACUTE-PHASE RESPONSE [J].
BAUMANN, H ;
GAULDIE, J .
IMMUNOLOGY TODAY, 1994, 15 (02) :74-80
[5]   Procalcitonin is a marker of severity of renal lesions in pyelonephritis [J].
Benador, N ;
Siegrist, CA ;
Gendrel, D ;
Greder, C ;
Benador, D ;
Assicot, M ;
Bohuon, C ;
Girardin, E .
PEDIATRICS, 1998, 102 (06) :1422-1425
[6]   Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults [J].
Bernard, L ;
Ferrière, F ;
Casassus, P ;
Malas, F ;
Lévêque, S ;
Guillevin, L ;
Lortholary, O .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (04) :914-915
[7]   Kinetics of procalcitonin in iatrogenic sepsis [J].
Brunkhorst, FM ;
Heinz, U ;
Forycki, ZF .
INTENSIVE CARE MEDICINE, 1998, 24 (08) :888-889
[8]   Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia [J].
deWerra, I ;
Jaccard, C ;
Corradin, SB ;
Chiolero, R ;
Yersin, B ;
Gallati, H ;
Assicot, M ;
Bohuon, C ;
Baumgartner, JD ;
Glauser, MP ;
Heumann, D .
CRITICAL CARE MEDICINE, 1997, 25 (04) :607-613
[9]  
Engel A, 1999, SCAND J INFECT DIS, V31, P185, DOI 10.1080/003655499750006254
[10]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454